Investigation of usability and efficacy of loratadine rapidly disintegrating tablets (Claritin® Reditabs®)

Masutaka Furue, Shinichi Imafuku

研究成果: Contribution to journalReview article査読

抄録

A questionnaire survey on the usability and efficacy of loratadine rapidly disintegrating tablets (Claritin® Reditabs®) was conducted in 64 patients with pruritic skin disease (17 with urticaria, 25 with atopic dermatitis, and 22 with other eczema/dermatitis). Regarding overall ease of ingestion, 54 patients (84.4%) considered it "good", 9 (14.1%) "neither good nor bad", and 0 (0%) "bad". Eleven patients (17.2%) sometimes "forgot to take" the drug and 53 (82.8%) did not forget to take the drug, with a significantly lower number of patinets "forgetting to take" the drug. Fifty-four patients (84.4%) stated that they wanted to continue the drug. The reasons for wanting to continue it (with multiple answers allowed) included "it is convenient to take the drug anywhere" for 28 patients (43.8%), "no need for water" for 25 (39.1%), and "once-daily ingestion" for 23 (35.9%). It was found that the rapidly disintegrating tablet dosage form improved drug compliance.

本文言語英語
ページ(範囲)195-198
ページ数4
ジャーナルNishinihon Journal of Dermatology
68
2
DOI
出版ステータス出版済み - 2006

All Science Journal Classification (ASJC) codes

  • Dermatology

フィンガープリント 「Investigation of usability and efficacy of loratadine rapidly disintegrating tablets (Claritin® Reditabs®)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル